XML 43 R24.htm IDEA: XBRL DOCUMENT v3.21.2

Collaborative Research and License Agreements (Tables)

9 Months Ended

Sep. 30, 2021

Research and Development [Abstract]

Balance Of The Company's Contract Liability

The following table presents changes in the balances of the Company’s contract liabilities (in thousands):

						Deferred Revenue Balance at January 1, 2021						Additions						Revenue (Recognized) Reversed						Deferred Revenue Balance at September 30, 2021
Ipsen Collaboration Agreement						$	—					$	20,000					$	(803)					$	19,197
AbbVie Collaboration Agreement						$	8,343					$	—					$	3,404					$	11,747
Total						$	8,343					$	20,000					$	2,601					$	30,944

X

- Definition

Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045

+ Details

Name:	us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration